-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Amgen, Raises Price Target to $470

Benzinga·11/04/2026 16:14:41
Listen to the news
RBC Capital analyst Luca Issi maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $430 to $470.